Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
22.31
+0.31 (1.41%)
Feb 5, 2025, 12:02 PM EST - Market open
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.09 billion as of February 5, 2025. Its market cap has increased by 84.83% in one year.
Market Cap
1.09B
Enterprise Value
783.15M
1-Year Change
84.83%
Ranking
Category
Stock Price
$22.31
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.09B, an increase of 11.91%. That is a compound annual growth rate of 5.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2025 | 1.07B | -2.22% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.32B |
| UnitedHealth Group | 499.25B |
| Novo Nordisk | 375.61B |
| Johnson & Johnson | 366.32B |
| AbbVie | 324.98B |
| Merck & Co. | 249.98B |
| Thermo Fisher Scientific | 228.64B |
| Abbott Laboratories | 221.89B |